World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
80
Citations
37361
World Ranking
3990
National Ranking
1969

David Gonzalez publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where David Gonzalez sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 343 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

David Gonzalez D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where David Gonzalez sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 80 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

David Gonzalez is affiliated with the University of California, San Diego in the United States and focuses primarily on the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work spans several subfields including Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Molecular Biology, and Genetics.

The researcher's publications cover a range of topics related to cancer diagnostics and treatment, molecular biology techniques, and clinical applications in oncology. Key research areas include Cancer Genomics and Diagnostics, Lymphoma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, PARP inhibition in cancer therapy, Molecular Biology Techniques and Applications, and Prostate Cancer Treatment and Research.

Recent papers authored or co-authored by David Gonzalez include:

  • "The New EU Regulation on In Vitro Diagnostic Medical Devices: Implications and Preparatory Actions for Diagnostic Laboratories," 2021, HemaSphere
  • "A novel next generation sequencing approach to improve sarcoma diagnosis," 2020, Modern Pathology
  • "Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer," 2021, The Journal of Pathology Clinical Research
  • "Homologous recombination repair deficiency (HRD): From biology to clinical exploitation," 2021, Genes Chromosomes and Cancer
  • "Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer," 2023, European Urology Oncology

Frequent co-authors collaborating with David Gonzalez include:

  • Peter Stewart (7 publications)
  • Jana Gazdová (6 publications)
  • Mark Catherwood (5 publications)
  • Shambhavi Srivastava (4 publications)
  • Albrecht Stenzinger (4 publications)

David Gonzalez's publications have appeared in multiple reputable venues, with frequent contributions to Blood, Histopathology, Scientific Reports, HemaSphere, and Modern Pathology.

  • Blood (3 publications)
  • Histopathology (2 publications)
  • Scientific Reports (2 publications)
  • HemaSphere (1 publication)
  • Modern Pathology (1 publication)

The research conducted by David Gonzalez primarily addresses key challenges in molecular diagnostics and clinical oncology, with a particular emphasis on homologous recombination repair mutation testing and cancer genomics applications in prostate cancer and sarcomas. Their work contributes to understanding diagnostic regulations, molecular testing pathways, and the biological mechanisms underlying DNA repair deficiencies in cancer.

Best Publications

  • Landscape of transcription in human cells

    Sarah Djebali;Carrie A. Davis;Angelika Merkel;Alex Dobin

  • Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking

    Mingxun Wang;Jeremy J Carver;Vanessa V Phelan;Laura M Sanchez

  • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

    J J M van Dongen;A W Langerak;M Brüggemann;P A S Evans

  • An integrated encyclopedia of DNA elements in the human genome

    Ian Dunham;Anshul Kundaje;Shelley F. Aldred;Patrick J. Collins

  • Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules.

    Sebastian Markmiller;Sahar Soltanieh;Kari L. Server;Raymond Mak

  • EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

    A. W. Langerak;P. J. T. A. Groenen;M. Brüggemann;K. Beldjord

  • Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A

    Kazuya Yamanaka;Kirk A. Reynolds;Roland D. Kersten;Katherine S. Ryan;Katherine S. Ryan

  • Germinal Center B Cell and T Follicular Helper Cell Development Initiates in the Interfollicular Zone

    Steven M. Kerfoot;Gur Yaari;Jaymin R. Patel;Kody L. Johnson

  • Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy

    Jason Park;Stephen H. Wrzesinski;Stephen H. Wrzesinski;Eric Stern;Michael Look

  • Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer.

    Vishal Singh;Beng San Yeoh;Benoit Chassaing;Xia Xiao

  • Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial

    Elizabeth C Smyth;Andrew Wotherspoon;Clare Peckitt;David Gonzalez

  • Live imaging of stem cell and progeny behaviour in physiological hair-follicle regeneration

    Panteleimon Rompolas;Elizabeth R. Deschene;Giovanni Zito;David G. Gonzalez

  • Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets: Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

    P. A. S. Evans;Ch Pott;P. J. T. A. Groenen;G. Salles

  • Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial

    David Gonzalez;Pilar Martinez;Rachel Wade;Sarah Hockley

  • Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms.

    Brian A Walker;Christopher P Wardell;Lorenzo Melchor;Annamaria Brioli

  • Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.

    Brian A. Walker;Christopher P. Wardell;Lorenzo Melchor;Sanna Hulkki

  • Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis

    Vincent S. Tagliabracci;James L. Engel;Sandra E. Wiley;Junyu Xiao

  • Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis

    Faith E. Davies;Ann M. Dring;Cheng Li;Andrew C. Rawstron

  • ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia.

    S Pospisilova;D Gonzalez;J Malcikova;M Trbusek

  • Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

    Andrew G. Nicholson;David Gonzalez;Pallav Shah;Matthew J. Pynegar

Frequent Co-Authors

Gareth J. Morgan
Gareth J. Morgan Boston University
Brian A Walker
Brian A Walker Indiana University – Purdue University Indianapolis
Pieter C. Dorrestein
Pieter C. Dorrestein University of California, San Diego
Victor Nizet
Victor Nizet University of California, San Diego
Faith E. Davies
Faith E. Davies New York University Langone Medical Center
Ramón García-Sanz
Ramón García-Sanz University of Salamanca
Estella Matutes
Estella Matutes University of Barcelona
Daniel Catovsky
Daniel Catovsky Institute of Cancer Research
Esko I. Kauppinen
Esko I. Kauppinen Aalto University
Albert G. Nasibulin
Albert G. Nasibulin Skolkovo Institute of Science and Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the fields of Biology and Biochemistry opens up diverse career opportunities, many of which increasingly benefit from advanced online degrees. For those interested in blending science with administration, cahme accredited online mha programs offer education in healthcare management that is recognized for its rigorous standards. This pathway suits students aiming for leadership roles in hospitals or clinical settings.

Nurses seeking career advancement might consider online dnp programs without clinicals, which allow professionals to gain terminal degrees in nursing practice while maintaining their current roles. Additionally, those looking for executive and academic positions can explore the best doctorate of healthcare administration programs. These programs emphasize high-level leadership and policy-making skills.

For students aiming to specialize in pharmaceuticals, enrolling in an online pharmacy school can provide the credentials needed for roles in research, patient care, or industry settings. Collectively, these online degree options make it possible to build a flexible, impactful career related to biology or biochemistry, all while benefiting from the convenience of distance learning.

Best Scientists Citing David Gonzalez

Trending Scientists

Recently Published Articles